Article Information
History
- March 27, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zhengyang Yu1,
- Maohuan Lin2,3,4,
- Zhanyu Liang1,
- Ying Yang2,3,4,
- Wen Chen5,
- Yonghua Wang5,
- Yangxin Chen2,3,4,*,
- Kaida Ning6,* and
- Li C. Xia1,*
- 1Department of Statistics and Financial Mathematics, School of Mathematics, South China University of Technology, Guangzhou, 510000, Guangdong, China
- 2Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, 510120, Guangdong, China
- 3Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
- 4Guangzhou Key Laboratory of Molecular Mechanism and Translation in Major Cardiovascular Disease, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
- 5School of Food Science and Engineering, South China University of Technology, Guangzhou 510640, Guangdong, China
- 6Peng Cheng Laboratory, Shenzhen, Guangdong, 518000, China
- ↵*Correspondence author. Li C. Xia, Email: lcxia{at}scut.edu.cn; Kaida Ning, Email: ningkd{at}pcl.ac.cn; Yangxin Chen, Email: chenyx39{at}mail.sysu.edu.cn
Posted March 27, 2024.
Multi-trait genome-wide analysis identified novel risk loci and candidate drugs for heart failure
